SEC Form 4 · accession 0001209191-16-129447
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Lawrence
Officer — Chief of Business Operations
Period of report
Jun 22, 2016
Accepted (ET)
Jun 24, 2016 · 7:34 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 22, 2016 | M | 500 | $8.50 | A | 9,702 | D | |
| Common StockF1 | Jun 22, 2016 | S | 500 | $25.09 | D | 9,202 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1,F2 | $8.50 | Jun 22, 2016 | M | 500 | D | — | Sep 25, 2016 | Common Stock | 500 | 0 | D |
Explanation of responses
- F1Exercise and sales pursuant to a 10b5-1 plan. The exercised options were scheduled to expire in 2016 on the expiration date reported within Table II unless exercised.
- F2The shares subject to these options vested in installments and were fully vested on September 25, 2010.